News

PRA International, a Clinical Research Organization, announced today the appointment of Dr. Jerome Wilson as Senior Medical Director of Late Phase Services.

Rare disease patients, academic researchers, NGOs and industry united their voices in a call to EU governments to take action this Autumn to address the issues facing patients affected by rare diseases in Europe.

Qualia Clinical Services, a division of Holmes Biopharma, selects ALPHADAS, Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.

Qualia Clinical Services, a division of Holmes Biopharma, selects ALPHADAS, Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.

PPD, Inc. has reported its financial and operating results for the third quarter ended September 30, 2008.

iCardiac announced today that it has completed a highly automated analysis of ECG data for a leading pharmaceutical firm?s Thorough QT (TQT) study.

Pharsight Corporation, a provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that is has initiated beta testing of its new Phoenix analysis and modeling software platform.

Perceptive Informatics, an eClinical technology provider and a subsidiary of PAREXEL International Corporation, announced the release of an enhanced version of its award-winning DataLabs Electronic Data Capture (EDC) and Clinical Data Management System (CDMS) solution to improve the efficiency and data quality of clinical studies.

ICON reports 35% increase in revenue and 45% increase in operating income.

SGS Leverages Phase Forward's InForm and Central Designer Solutions for Greater Clinical Trial Efficiencies

SGS Leverages Phase Forward's InForm and Central Designer Solutions for Greater Clinical Trial Efficiencies

Aris Global's Release of agXchange SIR Enables Trial Sponsors to Automate Investigator Safety Reporting and Reap Significant Cost Savings

ProTrials Research, Inc., today announced that it has been selected as a finalist for the 5th annual Stevie Awards for Women in Business.

First-cycle approval for NME produces $640 million in incremental revenue on average.

Inclinix, Inc., a contract research organization (CRO) specializing in clinical trial enrollment solutions, announces the expansion of its in-field Regional Recruitment Manager (RRM) team, including international and multi-lingual professionals.

C-TASC, a clinical trials solutions company, announced today that it will assist the FDA Centers for Quality Assurance and Biostatistics to develop new methods and procedures for evaluating all NDAs submitted for FDA approval.

Take a sneak peek at the in depth look into the successful first year of ACR Image Metrix, appearing in our November 2008 issue.

Velos has announced that the Duke University Health System (DUHS) has completed a successful go-live of the Velos eResearch system.

NM, an international scientific and medical association dedicated to advancing molecular imaging and therapy, has announced the creation of the Molecular Imaging Clinical Trials Network.

VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.

PharmaPros, a technical consulting and solutions provider has announced that FUJIFILM Medical Systems USA, a provider of diagnostic imaging products and network systems, has selected the company?s Dataflow Manager solution, and study support services to assist with Fujifilm clinical studies.

The contributions Eastern and Central European Member States make to the European Medicines Regulatory Network (EMRN) was the topic of the first session of the Fifth Annual TOPRA Annual Symposium in Budapest.

A new Web site from the National Institutes of Health (NIH), "Children and Clinical Studies," offers parents and health care providers an insider's guide to children's medical research.

Pharsight Corporation, a provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and InforSense Ltd., aprovider of next-generation business and scientific intelligence tools, announced that they have signed an agreement for InforSense to distribute Pharsight products in China through its Shanghai based subsidiary.

The European Commission (EC), the European Medicines Agency (EMEA) and the United States Food and Drug Administration (FDA) have affirmed their commitment to regulatory cooperation and to intensifying their interactions in several new areas.